IL207469A - Imidazolyl biphenyl imidazoles, compositions comprising same and use thereof for treating hepatitis c virus infection - Google Patents
Imidazolyl biphenyl imidazoles, compositions comprising same and use thereof for treating hepatitis c virus infectionInfo
- Publication number
- IL207469A IL207469A IL207469A IL20746910A IL207469A IL 207469 A IL207469 A IL 207469A IL 207469 A IL207469 A IL 207469A IL 20746910 A IL20746910 A IL 20746910A IL 207469 A IL207469 A IL 207469A
- Authority
- IL
- Israel
- Prior art keywords
- compositions
- same
- virus infection
- treating hepatitis
- imidazolyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2008/053779 WO2009102325A1 (en) | 2008-02-13 | 2008-02-13 | Imidazolyl biphenyl imidazoles as hepatitis c virus inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
IL207469A0 IL207469A0 (en) | 2010-12-30 |
IL207469A true IL207469A (en) | 2016-03-31 |
Family
ID=39661448
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL207469A IL207469A (en) | 2008-02-13 | 2010-08-08 | Imidazolyl biphenyl imidazoles, compositions comprising same and use thereof for treating hepatitis c virus infection |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP2242752B1 (en) |
JP (1) | JP5312486B2 (en) |
KR (1) | KR101492672B1 (en) |
CN (1) | CN102007122B (en) |
AU (1) | AU2008350334B2 (en) |
BR (1) | BRPI0822323A2 (en) |
CA (1) | CA2715839C (en) |
CY (1) | CY1113259T1 (en) |
DK (1) | DK2242752T3 (en) |
EA (1) | EA018088B1 (en) |
ES (1) | ES2391600T3 (en) |
HK (1) | HK1144194A1 (en) |
HR (1) | HRP20120706T1 (en) |
IL (1) | IL207469A (en) |
MX (1) | MX2010008863A (en) |
NZ (1) | NZ587557A (en) |
PL (1) | PL2242752T3 (en) |
PT (1) | PT2242752E (en) |
SI (1) | SI2242752T1 (en) |
WO (1) | WO2009102325A1 (en) |
ZA (1) | ZA201005573B (en) |
Families Citing this family (93)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7906655B2 (en) | 2008-08-07 | 2011-03-15 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US8383094B2 (en) | 2008-10-01 | 2013-02-26 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
CN102245604A (en) | 2008-12-23 | 2011-11-16 | 雅培制药有限公司 | Anti-viral compounds |
JP2012513409A (en) | 2008-12-23 | 2012-06-14 | アボット・ラボラトリーズ | Antiviral compounds |
US8242156B2 (en) | 2009-02-17 | 2012-08-14 | Enanta Pharmaceuticals, Inc. | Linked dibenzimidazole derivatives |
TWI438200B (en) | 2009-02-17 | 2014-05-21 | 必治妥美雅史谷比公司 | Hepatitis c virus inhibitors |
US8188132B2 (en) | 2009-02-17 | 2012-05-29 | Enanta Pharmaceuticals, Inc. | Linked dibenzimidazole derivatives |
US8394968B2 (en) | 2009-02-17 | 2013-03-12 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US8673954B2 (en) | 2009-02-27 | 2014-03-18 | Enanta Pharmaceuticals, Inc. | Benzimidazole derivatives |
US8101643B2 (en) | 2009-02-27 | 2012-01-24 | Enanta Pharmaceuticals, Inc. | Benzimidazole derivatives |
ES2606717T3 (en) | 2009-02-27 | 2017-03-27 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
US9765087B2 (en) | 2009-02-27 | 2017-09-19 | Enanta Pharmaceuticals, Inc. | Benzimidazole derivatives |
US8507522B2 (en) | 2009-03-06 | 2013-08-13 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
EA020898B1 (en) | 2009-03-27 | 2015-02-27 | Мерк Шарп Энд Домэ Корп. | Inhibitors of hepatitis c virus replication |
US20190127365A1 (en) | 2017-11-01 | 2019-05-02 | Merck Sharp & Dohme Corp. | Inhibitors of hepatitis c virus replication |
US8796466B2 (en) | 2009-03-30 | 2014-08-05 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
TW201038559A (en) | 2009-04-09 | 2010-11-01 | Bristol Myers Squibb Co | Hepatitis C virus inhibitors |
US8143414B2 (en) | 2009-04-13 | 2012-03-27 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
CN102459165B (en) | 2009-04-15 | 2015-09-02 | Abbvie公司 | Antiviral compound |
AR076765A1 (en) | 2009-05-13 | 2011-07-06 | Gilead Sciences Inc | ANTIVIRAL COMPOUNDS |
US8211928B2 (en) | 2009-05-29 | 2012-07-03 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US8138215B2 (en) | 2009-05-29 | 2012-03-20 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US9394279B2 (en) | 2009-06-11 | 2016-07-19 | Abbvie Inc. | Anti-viral compounds |
US8937150B2 (en) | 2009-06-11 | 2015-01-20 | Abbvie Inc. | Anti-viral compounds |
EP2853531A3 (en) | 2009-06-11 | 2015-08-12 | AbbVie Bahamas Ltd. | Antiviral compounds |
US8716454B2 (en) | 2009-06-11 | 2014-05-06 | Abbvie Inc. | Solid compositions |
US8221737B2 (en) | 2009-06-16 | 2012-07-17 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
US8609648B2 (en) | 2009-07-02 | 2013-12-17 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
US8354419B2 (en) | 2009-07-16 | 2013-01-15 | Vertex Pharmaceuticals Incorporated | Benzimidazole analogues for the treatment or prevention of flavivirus infections |
AU2010289762B2 (en) | 2009-09-04 | 2015-06-11 | Janssen Pharmaceuticals, Inc. | Chemical compounds |
US8815928B2 (en) | 2009-09-11 | 2014-08-26 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
US8759332B2 (en) | 2009-09-11 | 2014-06-24 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
US8703938B2 (en) | 2009-09-11 | 2014-04-22 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
US8822700B2 (en) | 2009-09-11 | 2014-09-02 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
US8927709B2 (en) | 2009-09-11 | 2015-01-06 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
EP2475256A4 (en) | 2009-09-11 | 2013-06-05 | Enanta Pharm Inc | Hepatitis c virus inhibitors |
US8415374B2 (en) | 2009-10-12 | 2013-04-09 | Bristol-Myers Squibb Company | Combinations of hepatitis C virus inhibitors |
UA108211C2 (en) | 2009-11-04 | 2015-04-10 | Янссен Рід Айрленд | Benzimidazole imidazole derivatives |
US20110274648A1 (en) | 2009-11-11 | 2011-11-10 | Bristol-Myers Squibb Company | Hepatitis C Virus Inhibitors |
US20110269956A1 (en) | 2009-11-11 | 2011-11-03 | Bristol-Myers Squibb Company | Hepatitis C Virus Inhibitors |
US20110281910A1 (en) | 2009-11-12 | 2011-11-17 | Bristol-Myers Squibb Company | Hepatitis C Virus Inhibitors |
US8653070B2 (en) | 2009-12-14 | 2014-02-18 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
US8377980B2 (en) * | 2009-12-16 | 2013-02-19 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US8362020B2 (en) | 2009-12-30 | 2013-01-29 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
BR112012018529A2 (en) | 2010-01-25 | 2016-08-09 | Enanta Pharm Inc | hepatitis c virus inhibitors, their pharmaceutical composition and their use, and method for inhibiting replication of an rna-containing virus |
US8933110B2 (en) | 2010-01-25 | 2015-01-13 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
US8623814B2 (en) | 2010-02-23 | 2014-01-07 | Enanta Pharmaceuticals, Inc. | Antiviral agents |
US8178531B2 (en) | 2010-02-23 | 2012-05-15 | Enanta Pharmaceuticals, Inc. | Antiviral agents |
WO2011109037A1 (en) | 2010-03-04 | 2011-09-09 | Enanta Pharmaceuticals, Inc. | Combination pharmaceutical agents as inhibitors of hcv replication |
CA2794145A1 (en) | 2010-03-24 | 2011-09-29 | Vertex Pharmaceuticals Incorporated | Analogues for the treatment or prevention of flavivirus infections |
WO2011127350A1 (en) | 2010-04-09 | 2011-10-13 | Enanta Pharmaceuticals, Inc. | Hepatitis c virus inhibitors |
WO2011153396A1 (en) | 2010-06-04 | 2011-12-08 | Enanta Pharmaceuticals, Inc | Hepatitis c virus inhibitors |
NZ605440A (en) | 2010-06-10 | 2014-05-30 | Abbvie Bahamas Ltd | Solid compositions comprising an hcv inhibitor |
AU2011276526A1 (en) | 2010-06-28 | 2013-01-10 | Vertex Pharmaceuticals Incorporated | Compounds and methods for the treatment or prevention of Flavivirus infections |
WO2012006060A1 (en) | 2010-06-28 | 2012-01-12 | Vertex Pharmaceuticals Incorporated | Compounds and methods for the treatment or prevention of flavivirus infections |
EP2603080A4 (en) | 2010-08-12 | 2014-01-22 | Enanta Pharm Inc | Hepatitis c virus inhibitors |
AU2011292040A1 (en) | 2010-08-17 | 2013-03-07 | Vertex Pharmaceuticals Incorporated | Compounds and methods for the treatment or prevention of Flaviviridae viral infections |
US8859595B2 (en) | 2010-08-26 | 2014-10-14 | Rfs Pharma, Llc | Potent and selective inhibitors of hepatitis C virus |
JP2013540122A (en) | 2010-09-29 | 2013-10-31 | メルク・シャープ・エンド・ドーム・コーポレイション | Fused tetracyclic compound derivatives and methods of use thereof for the treatment of viral diseases |
SG190785A1 (en) * | 2010-11-17 | 2013-07-31 | Gilead Sciences Inc | Antiviral compounds |
US20150031884A1 (en) * | 2010-12-15 | 2015-01-29 | Abbvie Inc. | Anti-viral compounds |
WO2012122716A1 (en) | 2011-03-17 | 2012-09-20 | Merck Sharp & Dohme Corp. | Tetracyclic xanthene derivatives and methods of use thereof for treatment of viral diseases |
US10201584B1 (en) | 2011-05-17 | 2019-02-12 | Abbvie Inc. | Compositions and methods for treating HCV |
EP2709455A4 (en) * | 2011-05-18 | 2014-11-05 | Enanta Pharm Inc | Processes for the preparation of 5-azaspiro[2.4]heptane-6-carboxylic acid and its derivatives |
WO2013016499A1 (en) | 2011-07-26 | 2013-01-31 | Vertex Pharmaceuticals Incorporated | Methods for preparation of thiophene compounds |
AU2012286853A1 (en) | 2011-07-26 | 2013-05-02 | Vertex Pharmaceuticals Incorporated | Thiophene compounds |
WO2013030750A1 (en) | 2011-09-01 | 2013-03-07 | Lupin Limited | Antiviral compounds |
EP2755981A4 (en) | 2011-09-14 | 2015-03-25 | Merck Sharp & Dohme | Silyl-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseases |
PE20141056A1 (en) | 2011-09-16 | 2014-09-05 | Gilead Pharmasset Llc | METHODS FOR THE TREATMENT OF HCV |
CA3119789A1 (en) | 2011-10-27 | 2013-05-02 | Massachusetts Institute Of Technology | Amino acid derivatives functionalized on the n-terminal capable of forming drug encapsulating microspheres |
SI2907816T1 (en) | 2011-11-16 | 2018-10-30 | Gilead Pharmasset Llc | Condensed imidazolylimidazoles as antiviral compounds |
MX340033B (en) | 2011-12-28 | 2016-06-21 | Janssen Sciences Ireland Uc | Hetero-bicyclic derivatives as hcv inhibitors. |
US9034832B2 (en) | 2011-12-29 | 2015-05-19 | Abbvie Inc. | Solid compositions |
AU2013217224B2 (en) | 2012-02-10 | 2017-04-06 | Lupin Limited | Antiviral compounds with a dibenzooxaheterocycle moiety |
CN103304551B (en) * | 2012-03-14 | 2017-06-13 | 北京凯因科技股份有限公司 | Hepatitis AG14361 |
EP2827876A4 (en) | 2012-03-22 | 2015-10-28 | Alios Biopharma Inc | Pharmaceutical combinations comprising a thionucleotide analog |
US20130309196A1 (en) | 2012-05-16 | 2013-11-21 | Gilead Sciences, Inc. | Antiviral compounds |
US9056860B2 (en) * | 2012-06-05 | 2015-06-16 | Gilead Pharmasset Llc | Synthesis of antiviral compound |
WO2014110687A1 (en) | 2013-01-16 | 2014-07-24 | Merck Sharp & Dohme Corp. | Thiazolyl-substitued tetracyclic compounds and methods of use thereof for treatment of viral diseases |
MD4595B1 (en) | 2013-01-31 | 2018-10-31 | Gilead Pharmasset Llc. | Combination formulation of two antiviral compounds |
TW201526899A (en) | 2013-02-28 | 2015-07-16 | Alios Biopharma Inc | Pharmaceutical compositions |
US11484534B2 (en) | 2013-03-14 | 2022-11-01 | Abbvie Inc. | Methods for treating HCV |
NZ716840A (en) | 2013-08-27 | 2017-06-30 | Gilead Pharmasset Llc | Combination formulation of two antiviral compounds |
EP3089757A1 (en) | 2014-01-03 | 2016-11-09 | AbbVie Inc. | Solid antiviral dosage forms |
JP2017513852A (en) * | 2014-04-15 | 2017-06-01 | コクリスタル ファーマ,インコーポレイテッド | Potent and selective inhibitors of hepatitis C virus |
WO2015184644A1 (en) * | 2014-06-06 | 2015-12-10 | 爱博新药研发(上海)有限公司 | Compounds and pharmaceutical compositions for inhibiting hepatitis c virus, and uses thereof |
TWI721947B (en) | 2014-06-11 | 2021-03-21 | 美商基利法瑪席特有限責任公司 | Solid forms of an antiviral compound |
PT3310764T (en) | 2015-06-19 | 2023-07-11 | Massachusetts Inst Technology | Alkenyl substituted 2,5-piperazinediones and their use in compositions for delivering an agent to a subject or cell |
CN106008316B (en) * | 2016-06-17 | 2018-04-27 | 成都百事兴科技实业有限公司 | A kind of method of synthesis Lei Dipawei chiral intermediates |
CN105967990A (en) * | 2016-07-05 | 2016-09-28 | 南京红杉生物科技有限公司 | 4,4'-bis(2-bromoacetyl) biphenyl synthesizing method |
US20190256498A1 (en) * | 2016-07-08 | 2019-08-22 | Lupin Limited | Crystalline forms of daclatasvir dihydrochloride |
EP3891508A1 (en) | 2018-12-04 | 2021-10-13 | Bristol-Myers Squibb Company | Methods of analysis using in-sample calibration curve by multiple isotopologue reaction monitoring |
CN111825659A (en) * | 2019-04-19 | 2020-10-27 | 扬子江药业集团有限公司 | Impurity hydrochloride of dalatavir hydrochloride, preparation method and application thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6080870A (en) * | 1996-04-03 | 2000-06-27 | Merck & Co., Inc. | Biaryl substituted imidazole compounds useful as farnesyl-protein transferase inhibitors |
EP1532118A2 (en) * | 2002-07-05 | 2005-05-25 | Axxima Pharmaceuticals Aktiengesellschaft | Imidazole compounds for the treatment of hepatitis c virus infections |
GB0416396D0 (en) * | 2004-07-22 | 2004-08-25 | Angeletti P Ist Richerche Bio | Therapeutic agents |
US8143288B2 (en) * | 2005-06-06 | 2012-03-27 | Bristol-Myers Squibb Company | Inhibitors of HCV replication |
US8329159B2 (en) * | 2006-08-11 | 2012-12-11 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US7759495B2 (en) * | 2006-08-11 | 2010-07-20 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US7659270B2 (en) * | 2006-08-11 | 2010-02-09 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
-
2008
- 2008-02-13 DK DK08768910.5T patent/DK2242752T3/en active
- 2008-02-13 CA CA2715839A patent/CA2715839C/en not_active Expired - Fee Related
- 2008-02-13 EA EA201001274A patent/EA018088B1/en not_active IP Right Cessation
- 2008-02-13 PT PT08768910T patent/PT2242752E/en unknown
- 2008-02-13 JP JP2010546739A patent/JP5312486B2/en not_active Expired - Fee Related
- 2008-02-13 PL PL08768910T patent/PL2242752T3/en unknown
- 2008-02-13 EP EP08768910A patent/EP2242752B1/en not_active Not-in-force
- 2008-02-13 MX MX2010008863A patent/MX2010008863A/en active IP Right Grant
- 2008-02-13 AU AU2008350334A patent/AU2008350334B2/en not_active Ceased
- 2008-02-13 KR KR20107020264A patent/KR101492672B1/en not_active IP Right Cessation
- 2008-02-13 CN CN2008801286329A patent/CN102007122B/en not_active Expired - Fee Related
- 2008-02-13 ES ES08768910T patent/ES2391600T3/en active Active
- 2008-02-13 NZ NZ587557A patent/NZ587557A/en not_active IP Right Cessation
- 2008-02-13 SI SI200830809T patent/SI2242752T1/en unknown
- 2008-02-13 BR BRPI0822323-8A patent/BRPI0822323A2/en not_active IP Right Cessation
- 2008-02-13 WO PCT/US2008/053779 patent/WO2009102325A1/en active Application Filing
-
2010
- 2010-08-04 ZA ZA2010/05573A patent/ZA201005573B/en unknown
- 2010-08-08 IL IL207469A patent/IL207469A/en not_active IP Right Cessation
- 2010-11-08 HK HK10110401.0A patent/HK1144194A1/en not_active IP Right Cessation
-
2012
- 2012-09-05 HR HRP20120706AT patent/HRP20120706T1/en unknown
- 2012-10-26 CY CY20121101023T patent/CY1113259T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI0822323A2 (en) | 2015-06-16 |
DK2242752T3 (en) | 2012-11-19 |
AU2008350334A1 (en) | 2009-08-20 |
ES2391600T3 (en) | 2012-11-28 |
EA201001274A1 (en) | 2011-06-30 |
CA2715839C (en) | 2014-12-09 |
CN102007122B (en) | 2013-09-04 |
EP2242752B1 (en) | 2012-08-08 |
PL2242752T3 (en) | 2012-12-31 |
WO2009102325A1 (en) | 2009-08-20 |
HK1144194A1 (en) | 2011-02-02 |
HRP20120706T1 (en) | 2012-09-30 |
JP2011511833A (en) | 2011-04-14 |
KR20100113629A (en) | 2010-10-21 |
CA2715839A1 (en) | 2009-08-20 |
EA018088B1 (en) | 2013-05-30 |
MX2010008863A (en) | 2010-09-07 |
IL207469A0 (en) | 2010-12-30 |
SI2242752T1 (en) | 2013-03-29 |
EP2242752A1 (en) | 2010-10-27 |
CN102007122A (en) | 2011-04-06 |
NZ587557A (en) | 2012-04-27 |
KR101492672B1 (en) | 2015-02-16 |
CY1113259T1 (en) | 2016-04-13 |
AU2008350334B2 (en) | 2013-10-17 |
ZA201005573B (en) | 2012-01-25 |
PT2242752E (en) | 2012-10-29 |
JP5312486B2 (en) | 2013-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL207469A (en) | Imidazolyl biphenyl imidazoles, compositions comprising same and use thereof for treating hepatitis c virus infection | |
HK1250936A1 (en) | Compositions and methods for treating viral infections | |
IL270877B (en) | Hepatitis b virus inhibitory double-stranded rna,compositions comprising the same and uses thereof | |
SI2193131T1 (en) | Imidazos1,2-acpyrazine compounds for treatment of viral infections such as hepatitis | |
HK1143812A1 (en) | Hepatitis c virus inhibitors | |
IL207470A0 (en) | Hepatitis c virus inhibitors | |
WO2011056650A9 (en) | Methods and compositions for treating and preventing viral infections | |
IL220625A (en) | Isoindolinone compounds, compositions comprising the same and uses thereof | |
HK1133158A1 (en) | Clothing for protecting infection syndrome | |
GB0816679D0 (en) | Compounds for treating viral infections | |
IL200905A0 (en) | Compounds and compositions comprising the same for use in treating hepatitis c | |
EP2531025A4 (en) | Method for treating fungal infections, fungicidal compositions and their use | |
EP2341924A4 (en) | Methods of treating hepatitis c virus infection | |
ZA201205547B (en) | Therapies for treating hepatitis c virus infection | |
IL207639A0 (en) | Pyrrolopyrimidinecarboxamide compounds, compositions comprising the same and uses thereof | |
EP2120988A4 (en) | Treating hepatitis c virus infection | |
ZA201103254B (en) | Triazole and imidazole compounds,use thereof and agents containing them | |
TWI370736B (en) | Pharmaceutical composition for treating hepatitis b and heath food for inhibiting hepatitis b virus | |
EP2341776A4 (en) | Compounds, compositions and methods comprising imidazole and triazole derivatives | |
IL213593A0 (en) | Hepatitis c virus combination therapy | |
ZA201102171B (en) | Treatment with hepatitis c infection with metalloporphyrins | |
EP2515903A4 (en) | Compounds, preparations and uses thereof | |
EP2578659A4 (en) | Water-and-oil repellent agent, and water-and-oil repellent agent composition | |
EP2326340A4 (en) | Compositions and methods for treating s. pneumoniae infection | |
ZA201205639B (en) | Compositions and methods for treating hepatitis b virus infection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
MM9K | Patent not in force due to non-payment of renewal fees |